SCHEMBL1243993

SCHEMBL1243993

CCC(CC)(C1CCCCN1)P(=O)(O)O

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.46
CCR2 P41597 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8672430 0.74 FDPS (0.51) FDPS
SCHEMBL7498448 0.71 FDPS (0.36) FDPSCCR2
SCHEMBL22461930 0.71 FDPS (0.36) FDPSCCR2
SCHEMBL13930833 0.70 CCR2 (0.32) FDPSCCR2
SCHEMBL22570154 0.70 CCR2 (0.32) FDPSCCR2
SCHEMBL24317161 0.70 CCR2 (0.32) FDPSCCR2
SCHEMBL17307730 0.70 CCR2 (0.32) FDPSCCR2
SCHEMBL27504819 0.69 KDM4E (0.35) FDPS
SCHEMBL973001 0.69 FDPS (0.33) FDPS
SCHEMBL20850792 0.69 FDPS (0.36) FDPSCCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879878-B2 such as {2-[({[7-(cyclohexylamino)-6-fluoro-4-oxo-1-[(3S)-tetrahydrofuran-3-yl]-1,4-dihydroquinolin-3-yl}carbonyl)amino]ethyl}phosphonic acid, used as platelet aggregation inhibitor and purinergic receptor (P2Y12) inhibitors; therapy for circulatory diseases involving thrombosis via platelet aggregation ASTELLAS PHARMA INC. (JP) 2011-02-01 US disclosed